<?xml version='1.0' encoding='utf-8'?>
<document id="30973998"><sentence text="Effects of the P-Glycoprotein Inhibitor Clarithromycin on the Pharmacokinetics of Intravenous and Oral Trospium Chloride: A 4-Way Crossover Drug-Drug Interaction Study in Healthy Subjects."><entity charOffset="40-54" id="DDI-PubMed.30973998.s1.e0" text="Clarithromycin" /><entity charOffset="103-120" id="DDI-PubMed.30973998.s1.e1" text="Trospium Chloride" /><pair ddi="false" e1="DDI-PubMed.30973998.s1.e0" e2="DDI-PubMed.30973998.s1.e0" /><pair ddi="false" e1="DDI-PubMed.30973998.s1.e0" e2="DDI-PubMed.30973998.s1.e1" /></sentence><sentence text="The quaternary ammonium compound trospium chloride is poorly absorbed from 2 &quot;absorption windows&quot; in the jejunum and cecum/ascending colon, respectively"><entity charOffset="4-23" id="DDI-PubMed.30973998.s2.e0" text="quaternary ammonium" /><entity charOffset="33-50" id="DDI-PubMed.30973998.s2.e1" text="trospium chloride" /><pair ddi="false" e1="DDI-PubMed.30973998.s2.e0" e2="DDI-PubMed.30973998.s2.e0" /><pair ddi="false" e1="DDI-PubMed.30973998.s2.e0" e2="DDI-PubMed.30973998.s2.e1" /></sentence><sentence text=" To confirm whether intestinal P-glycoprotein (P-gp) is involved, a 4-period, crossover drug interaction study with trospium chloride after intravenous (2 mg) and oral administration (30 mg) without and after comedication of clarithromycin (500 mg), an inhibitor for P-gp, was initiated in 12 healthy subjects"><entity charOffset="116-133" id="DDI-PubMed.30973998.s3.e0" text="trospium chloride" /><entity charOffset="225-239" id="DDI-PubMed.30973998.s3.e1" text="clarithromycin" /><pair ddi="false" e1="DDI-PubMed.30973998.s3.e0" e2="DDI-PubMed.30973998.s3.e0" /><pair ddi="false" e1="DDI-PubMed.30973998.s3.e0" e2="DDI-PubMed.30973998.s3.e1" /></sentence><sentence text=" Pharmacokinetics of trospium was evaluated using gas chromatography-mass spectrometry, noncompartmental evaluation, and pharmacokinetic modeling"><entity charOffset="21-29" id="DDI-PubMed.30973998.s4.e0" text="trospium" /></sentence><sentence text=" Trospium chloride was poorly absorbed after oral administration (absolute bioavailability, ∼8%-10%)"><entity charOffset="1-18" id="DDI-PubMed.30973998.s5.e0" text="Trospium chloride" /></sentence><sentence text=" About 30% of the bioavailable dose fraction was absorbed from the &quot;narrow window&quot;" /><sentence text=" Comedication with clarithromycin increased steady-state distribution volumes by ∼27% (P &lt; "><entity charOffset="19-33" id="DDI-PubMed.30973998.s7.e0" text="clarithromycin" /></sentence><sentence text="01)" /><sentence text=" Bioavailability was not increased as hypothesized" /><sentence text=" The geometric mean ratios (90% confidence interval) for area under the plasma concentration-time curve, maximum concentration, and renal clearance accounted for 0" /><sentence text="75 (0" /><sentence text="56-1" /><sentence text="01), 0" /><sentence text="64 (0" /><sentence text="45-0" /><sentence text="89), and 1" /><sentence text="00 (0" /><sentence text="90-1" /><sentence text="13), respectively" /><sentence text=" The amount of trospium absorbed from the &quot;narrow window&quot; was reduced in all subjects but from the &quot;wider window&quot; in only 9 of them"><entity charOffset="15-23" id="DDI-PubMed.30973998.s20.e0" text="trospium" /></sentence><sentence text=" Bioavailability was strongly predicted by the maximum absorption rate of trospium in the distal &quot;window&quot; (rs2  = 0"><entity charOffset="74-82" id="DDI-PubMed.30973998.s21.e0" text="trospium" /></sentence><sentence text="910, P &lt; " /><sentence text="0001)" /><sentence text=" In conclusion, the P-gp inhibitor clarithromycin significantly increases distribution volumes but not oral absorption of trospium"><entity charOffset="35-49" id="DDI-PubMed.30973998.s24.e0" text="clarithromycin" /><entity charOffset="122-130" id="DDI-PubMed.30973998.s24.e1" text="trospium" /><pair ddi="false" e1="DDI-PubMed.30973998.s24.e0" e2="DDI-PubMed.30973998.s24.e0" /><pair ddi="false" e1="DDI-PubMed.30973998.s24.e0" e2="DDI-PubMed.30973998.s24.e1" /></sentence><sentence text=" The amount absorbed from the &quot;narrow window&quot; was lowered in all subjects" /><sentence text=" However, the extent of all influences seems not to be of clinical relevance" /><sentence text="" /></document>